That means the default pathway to market is the same gauntlet every pharmaceutical faces: preclinical studies, Investigational New Drug (IND) applications, phased clinical trials, and a New Drug Application (NDA) (or an Abbreviated New Drug Application (ANDA) for generics)
However, insurance doesn't always cover GLP-1 injections and the cost makes them less accessible to everyone
Strategic Breakthrough Awards Create a New Funding Tier The reauthorization formally established the Strategic Breakthrough Award, a new funding mechanism that scales up the transition-focused programs the Department had already been running informally across its components
The compound is identified by CAS Number 170851-70-4 and features a well-defined molecular structure with the formula CHNO and a molecular weight of 711.85 g/mol
Additionally, final 503B guidance released in January 2025 states that 503B facilities cannot compound using bulk drug substances while the FDA is deciding whether or not to place the ingredient on the bulk drug substance list